Sitadapa 50/5MG Tab 10S — Uses, Dosage & Benefits

Sitagliptin 50 mg + Dapagliflozin 5 mg (as tablets)

Sitagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing glucose-dependent insulin release and reducing glucagon. Dapagliflozin is an SGLT2 inhibitor that reduces renal glucose reabsorption, increasing urinary glucose excretion and lowering blood glucose.

Oral tablet. Take exactly as prescribed, usually once daily, with or without food. Maintain adequate hydration; follow diet/exercise plan and monitor blood glucose as advised.

Always follow your doctor's prescription. Do not self-medicate.